According to a secondary analysis of the 24- Month Myopia Outcome Study of Atropine in Children (MOSAIC) trial, 0.05% atropine eye drops were more effective in controlling myopia progression and axial ...
Please provide your email address to receive an email when new articles are posted on . Eyenovia’s phase 3 CHAPERONE study evaluating low-dose atropine delivered via the company’s Optejet dispenser is ...
Please provide your email address to receive an email when new articles are posted on . The new drug application is supported by 3-year data from the STAR study. If approved, SYD-101 would be the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback